ZUTAYNLI

EUIPO EUIPO 2020 Application withdrawn

Protect this trademark from copycats!

With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.

The Union trademark ZUTAYNLI was filed as Word mark on 11/06/2020 at the European Union Intellectual Property Office. The current status of the mark is "Application withdrawn".

Trademark Details Last update: February 8, 2024

Trademark form Word mark
File reference 018334073
Application date November 6, 2020
Publication date February 3, 2021

Trademark owner

Lilly Corporate Center
46285 Indianapolis,
US

Trademark representatives

Widenmayerstr. 10 80538 München DE

goods and services

5 Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment, prevention and/or diagnosis of alopecia, Alzheimer's disease, atopic dermatitis, autoimmune diseases and disorders, blood diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders; pharmaceutical preparations for the treatment, prevention and/or diagnosis of cluster headaches, Coronavirus disease, Crohn's disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders; pharmaceutical preparations for the treatment, prevention and/or diagnosis of fibromyalgia, gastrointestinal diseases and disorders, headaches, heart failure, inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, lupus, mental disorders, metabolic diseases and disorders, migraines, neurodegenerative diseases and disorders; pharmaceutical preparations for the treatment, prevention and/or diagnosis of neurological disorders, obesity, osteoarthritis, pain, Parkinson's disease, Psoriasis, Psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and vascular diseases; Diagnostic agents, preparations and substances for medical purposes; diagnostic scanning agents for medical use, namely, diagnostic scanning agents for in vivo use; radiopharmaceutical diagnostic preparations for medical use; radiopharmaceutical diagnostic preparations for use in the diagnosis of neurodegenerative amyloid diseases; pharmaceutical preparations

Trademark history

Date Document number Area Entry
November 24, 2020 Change Representative, Registered

ID: 11018334073